Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia - Wikidata - awgldk - TriplyDB

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

http://www.wikidata.org/entity/Q28262015

about

Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes Calcium Dynamics Mediated by the Endoplasmic/Sarcoplasmic Reticulum and Related Diseases.Characterization of Two Human Skeletal Calsequestrin Mutants Implicated in Malignant Hyperthermia and Vacuolar Aggregate Myopathy The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles.Modeling heart disease in a dish: from somatic cells to disease-relevant cardiomyocytes.Characterization of Post-Translational Modifications to Calsequestrins of Cardiac and Skeletal Muscle.Induced pluripotent stem cell-derived cardiomyocytes: boutique science or valuable arrhythmia model?The emerging role of calmodulin regulation of RyR2 in controlling heart rhythm, the progression of heart failure and the antiarrhythmic action of dantrolene.Calcium Signaling and Cardiac Arrhythmias.Sudden death during struggle in the setting of heterozygosity for a mutation in calsequesterin 2.Compound heterozygous CASQ2 mutations and long-term course of catecholaminergic polymorphic ventricular tachycardia.Conditional ablation and conditional rescue models for Casq2 elucidate the role of development and of cell type specific expression of Casq2 in the CPVT2 phenotype.Proarrhythmic Remodeling of Calcium Homeostasis in Cardiac Disease; Implications for Diabetes and Obesity

P2860

Q28255887-4C4810F4-E837-41A0-9339-A753D6B2EF8F Q33755195-C32C7855-0646-4643-B349-D6E0166D8586 Q36323404-0A5157D9-B093-4A23-B94E-081B5E5CFBF6 Q36688514-B0CA2186-E6D4-4173-859C-90919930C42C Q37143372-91AE107D-6D14-4E80-8691-E5E5A6DB3037 Q37286588-2204AE27-AD33-4578-A3AD-2077A18B63E4 Q38097414-ABA92C63-0C1A-493A-B183-E29E12EDBE5F Q38954106-C5C40ED3-28B7-492B-98E6-C9E79DB19C2B Q39360546-51D11C77-53F5-421B-B4F3-AA677E2774A1 Q48044779-476AE531-3C79-426C-A228-AEB7FA0DAA3C Q48230851-9A218EC1-F9AE-4754-B50C-BDA48F4563A9 Q49922723-6BDA5777-CF98-463A-AB7E-8396BD41120C Q58693859-34E5B5C1-AED5-4975-B5CA-D051C6798BE9

P2860

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

http://www.wikidata.org/entity/Q28262015

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@ast

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@en

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@nl

type

label

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@ast

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@en

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@nl

prefLabel

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@ast

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@en

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@nl

P1433

Q28262015-200A63E7-5BF2-4DB8-9658-41ADE4EF45F9

P1476

Q28262015-D08E0D4E-5395-45DF-8C07-94824C8D6518

P2093

Q28262015-782568AE-9065-4466-9D8F-C189EF390CAA

Q28262015-7CEF8BA7-FA95-4F09-9C6C-ABB31780FC55

P2860

Q28262015-01F2E789-9E82-4612-8979-0D44370396CD

Q28262015-0CFF3200-12AD-4EBF-97E8-E55E6F6D7106

Q28262015-0DC24A87-0842-4412-8DD6-467A591A960A

Q28262015-10CA8811-118C-4C6B-A9AB-49B2C84961E6

Q28262015-1B6AD531-C44A-40F6-8BC6-116D199162C4

Q28262015-1BA179C2-A348-4B57-BC52-A2E4438DDF5E

Q28262015-20E7950D-0AD6-4E53-88DB-A416F06F1FB7

Q28262015-274D5393-4F9E-4363-ADAB-FC5E2DB477D3

Q28262015-27A02058-CDD0-4A2A-A651-51C78DC305B7

Q28262015-2AFD6866-2820-46CE-B129-70960D251EA3

P2888

Q28262015-6324D64F-86B1-4DD7-B621-2A4603593021

P304

Q28262015-C9BA966E-5F2B-418A-88F5-458FD2EDF65C

P31

Q28262015-5CA3BFF5-0B2A-4526-81DC-67A58C05D5ED

P3181

Q28262015-B41A0C6F-9042-4924-B4A4-000F984CF186

P356

Q28262015-D0919859-B6A1-4E1F-8E2D-482C66963EE1

P407

Q28262015-7267855B-CFD7-4AA8-9DB4-010859C77BF4

P433

Q28262015-A7C19F5B-F6E9-48B7-B5B0-EF0F4FF31EDA

P478

Q28262015-AA38693D-73EB-4931-9C48-2DDA3FD2D1C8

P50

Q28262015-D0875962-7487-4632-9EC4-CADA0ACAD833

P577

Q28262015-D70B58E8-11C6-4437-93A0-B3AD419DBD49

P5875

Q28262015-AD562B1C-838C-471E-88CE-791C1765659C

P6179

Q28262015-ED550E19-6BCB-498B-BB19-39DA6A88C80A

P698

Q28262015-5AE9F143-E363-4492-9793-23111E5B0780

P921

Q28262015-8E907F72-B4B4-4270-96EF-EF0B1FF32E79

Q28262015-C89C1F60-FA71-4D51-AB77-3153DA2ECEF3

P932

Q28262015-D6758706-8D31-4946-8A62-9610302AF03D

P3181

P356

S00246-012-0256-1

P1433

Pediatric Cardiology

P1476

Calsequestrin mutations and catecholaminergic polymorphic ventricular tachycardia

@en

P2093

Dmytro O Kryshtal

http://www.w3.org/2001/XMLSchema#string

Michela Faggioni

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical phenotype and functional characterization of CASQ2 mutations associated with catecholaminergic polymorphic ventricular tachycardia

Abnormal interactions of calsequestrin with the ryanodine receptor calcium release channel complex linked to exercise-induced sudden cardiac death

The role of calsequestrin, triadin, and junctin in conferring cardiac ryanodine receptor responsiveness to luminal calcium.

Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans

Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death

Crystal structure of calsequestrin from rabbit skeletal muscle sarcoplasmic reticulum

Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia

A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel

Cardiac excitation-contraction coupling

Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia

P2888

s00246-012-0256-1

P304

959-967

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3549463

http://www.w3.org/2001/XMLSchema#string

P356

10.1007/S00246-012-0256-1

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Bjorn C. Knollmann

P577

2012-03-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221708831

http://www.w3.org/2001/XMLSchema#string

P6179

1043186876

http://www.w3.org/2001/XMLSchema#string

P698

22421959

http://www.w3.org/2001/XMLSchema#string

P921

catecholaminergic polymorphic ventricular tachycardia

P932

3393815

http://www.w3.org/2001/XMLSchema#string